Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesT-Cell Vaccination Reduces Simian Immunodeficiency Virus Levels in Semen
Journal of Virology, 09/30/09
Whitney JB et al. – The authors show that vaccine–elicited cellular immune responses can significantly reduce simian immunodeficiency virus levels in the semen during the period of primary infection in monkeys. A vaccine that decreases the quantity of HIV–1 in the semen of males during primary infection might decrease HIV–1 transmission in human populations and therefore affect the spread of AIDS.
Related Articles
CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09
Relevance Score: 99%
A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study
British Journal of Cancer, 10/09/09
Relevance Score: 97%
One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09
Relevance Score: 97%
Human Papillomavirus Vaccine Uptake, Predictors of Vaccination, and Self-Reported Barriers to Vaccination
Journal of Women's Health, 10/05/09
Relevance Score: 96%
H1N1 Vaccine Deliveries Begin. Early Doses to Arrive This Week
American Family Physician, 10/07/09
Relevance Score: 95%
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Patterns of Influenza Vaccination among Medical Students
Infection Control and Hospital Epidemiology, 12/03/09
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years : The Lancet
The Lancet - Early Online Publication, 12/03/09
Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991–2009
Expert Review of Vaccines, 12/02/09
Article Search
Sponsor